谷氨基素1通过影响蛋白S-谷氨基化来调节胆固醇代谢和胆结石的形成
Yan Xia1, Ying Xu1, Qinhui Liu1
1Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Metabolism: clinical and experimental
|June 5, 2023
概括
谷氨素-1 (Glrx1) 通过增加胆固醇吸收和改变胆酸代谢,促进胆固醇胆结石的形成. 抑制Glrx1可能为胆结石疾病提供新的治疗方法.
科学领域:
- 生物化学 生物化学
- 代谢疾病 代谢疾病
- 分子生物学分子生物学
背景情况:
- 胆固醇胆结石疾病 (CGD) 与胆固醇代谢障碍有关.
- 谷氨基素-1 (Glrx1) 和其相关的S-谷氨基化与代谢疾病有关.
- Glrx1在胆固醇代谢和CGD中的作用在很大程度上尚未被探索.
研究的目的:
- 为了研究Glrx1在胆固醇胆结石形成中的作用.
- 阐明 Glrx1 影响胆固醇代谢和胆结石发育的机制.
主要方法:
- 运用了由饮食诱导的石化性小鼠模型.
- 生成的 Glrx1 缺乏和肝脏 Glrx1 过度表达的小鼠.
- 雇佣了免疫阻塞,qPCR,定量蛋白质组学和免疫沉.
主要成果:
- Glrx1被上调,S-氨基化减少在肝脏的小鼠在一个 lithogenic饮食.
- Glrx1 缺乏保护胆结石的形成,降低胆道胆固醇和胆固醇和指数 (CSI).
- Glrx1的过度表达加剧了胆结石的进展,改变了胆酸成分,增加了肠道胆固醇的吸收 (通过Cyp8b1),并影响了ASGR1脱谷化,影响了LXRα和胆固醇分泌.
结论:
- Glrx1通过调节胆固醇代谢,在胆结石形成中发挥重要作用.
- Glrx1通过增加胆酸依赖的胆固醇吸收和ASGR1-LXRα依赖的胆固醇流动来促进胆结石.
- 抑制 Glrx1 活性是胆病的潜在治疗策略.
相关概念视频
Cholesterol: Significance and Regulation
608
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
608
Sulfur Assimilation
45
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
45
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
272
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
272
Protein Modifications in the RER
5.3K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.3K
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K


